Sunshine Biopharma Inc Warrant
SBFMW
4 hedge funds and large institutions have $15.4K invested in Sunshine Biopharma Inc Warrant in 2023 Q3 according to their latest regulatory filings, with 0 funds opening new positions, 1 increasing their positions, 3 reducing their positions, and 1 closing their positions.
0.32% less ownership
Funds ownership: 0.58% → 0.27% (-0.32%)
20% less funds holding
Funds holding: 5 → 4 (-1)
67% less repeat investments, than reductions
Existing positions increased: 1 | Existing positions reduced: 3
71% less capital invested
Capital invested by funds: $53.3K → $15.4K (-$37.8K)
100% less first-time investments, than exits
New positions opened: 0 | Existing positions closed: 1
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Citadel Advisors
Miami,
Florida
|
+$10.8K |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
UBS Group
Zurich,
Switzerland
|
-$25.7K |
| 2 |
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
|
-$5.91K |
| 3 |
Bank of America
Charlotte,
North Carolina
|
-$62 |
| 4 |
CS
Clear Street
New York
|
-$62 |
| Name | Holding | Trade Value |
Shares Change |
Change in Stake |
|
|---|---|---|---|---|---|
|
1
Citadel Advisors
Miami,
Florida
| $14.8K | +$10.8K | +34,708 | +111% |
|
|
CS
2
Clear Street
New York
| $489 | -$62 | -200 | -8% |
|
|
3
UBS Group
Zurich,
Switzerland
| $149 | -$25.7K | -82,471 | -99% |
|
|
4
Bank of America
Charlotte,
North Carolina
| $22 | -$62 | -200 | -67% |
|
|
5
Susquehanna International Group
Bala Cynwyd,
Pennsylvania
| – | -$5.91K | -12,302 | Closed |
|
SBFMW Hedge Fund Activity: Q3 2023 in Review
4 of the 6,302 institutional investors tracked by Wall St. Rank reported a position in Sunshine Biopharma Inc Warrant (SBFMW) for Q3 2023, worth a combined $15.4K — down 71% from $53.3K a quarter earlier.
Sellers outnumbered buyers: 1 fund closed out of SBFMW and 0 opened new positions — a net loss of 1 holder — while 3 trimmed existing stakes and 1 added.
The largest buyer was Citadel Advisors, adding an estimated $10.8K. The largest seller was UBS Group, cutting an estimated $25.7K.
- 4 institutional investors held Sunshine Biopharma Inc Warrant (SBFMW) as of Q3 2023, down from 5 in Q2 2023.
- Funds reported $15.4K of Sunshine Biopharma Inc Warrant stock for Q3 2023, down 71% quarter-over-quarter.
- 0 funds opened new Sunshine Biopharma Inc Warrant positions in Q3 2023 and 1 closed out, a net change of -1 holder.
- The largest Sunshine Biopharma Inc Warrant buyer in Q3 2023 was Citadel Advisors, an estimated $10.8K added.
- The largest Sunshine Biopharma Inc Warrant seller in Q3 2023 was UBS Group, an estimated $25.7K sold.
Based on aggregated 13F filings for Q3 2023.